All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for FERRING PHARMACEUTICALS INC. · biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $50,000.00 income · posted Jul 20, 2026

Official filing document

Lobbying activity 3

Trade (domestic/foreign)

Issues related to pharmaceutical tariffs

Health Issues

Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA IVF Tax credit FDA Review programs

Veterans

Issues related to veteran's care and veteran's reproductive care

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.